Progyny (PGNY) Competitors $22.51 -0.66 (-2.85%) Closing price 04:00 PM EasternExtended Trading$22.52 +0.00 (+0.02%) As of 05:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PGNY vs. RDNT, OPCH, SHC, BTSG, WGS, CON, SGRY, PRVA, HTFL, and VCYTShould you be buying Progyny stock or one of its competitors? The main competitors of Progyny include RadNet (RDNT), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), GeneDx (WGS), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Privia Health Group (PRVA), Heartflow (HTFL), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. Progyny vs. Its Competitors RadNet Option Care Health Sotera Health BrightSpring Health Services GeneDx Concentra Group Holdings Parent Surgery Partners Privia Health Group Heartflow Veracyte RadNet (NASDAQ:RDNT) and Progyny (NASDAQ:PGNY) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, media sentiment, earnings, risk and dividends. Do analysts prefer RDNT or PGNY? RadNet presently has a consensus target price of $76.80, suggesting a potential upside of 3.77%. Progyny has a consensus target price of $25.30, suggesting a potential upside of 12.39%. Given Progyny's higher possible upside, analysts clearly believe Progyny is more favorable than RadNet.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RadNet 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 3 Strong Buy rating(s) 3.25Progyny 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.73 Which has more volatility & risk, RDNT or PGNY? RadNet has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500. Comparatively, Progyny has a beta of 1.33, indicating that its stock price is 33% more volatile than the S&P 500. Does the media favor RDNT or PGNY? In the previous week, RadNet had 4 more articles in the media than Progyny. MarketBeat recorded 14 mentions for RadNet and 10 mentions for Progyny. Progyny's average media sentiment score of 1.26 beat RadNet's score of 1.13 indicating that Progyny is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 8 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Progyny 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Is RDNT or PGNY more profitable? Progyny has a net margin of 4.28% compared to RadNet's net margin of -0.78%. Progyny's return on equity of 10.69% beat RadNet's return on equity.Company Net Margins Return on Equity Return on Assets RadNet-0.78% 2.41% 0.82% Progyny 4.28%10.69%7.12% Do insiders & institutionals have more ownership in RDNT or PGNY? 77.9% of RadNet shares are held by institutional investors. Comparatively, 94.9% of Progyny shares are held by institutional investors. 5.6% of RadNet shares are held by insiders. Comparatively, 9.4% of Progyny shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has higher valuation & earnings, RDNT or PGNY? Progyny has lower revenue, but higher earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRadNet$1.83B3.11$2.79M-$0.20-370.05Progyny$1.17B1.66$54.34M$0.5938.15 SummaryProgyny beats RadNet on 11 of the 17 factors compared between the two stocks. Get Progyny News Delivered to You Automatically Sign up to receive the latest news and ratings for PGNY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PGNY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PGNY vs. The Competition Export to ExcelMetricProgynyMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.99B$7.68B$5.86B$10.15BDividend YieldN/A2.76%5.68%4.59%P/E Ratio38.1574.0174.5225.93Price / Sales1.6642.61539.62123.65Price / Cash67.1424.1437.5660.44Price / Book4.547.3512.166.29Net Income$54.34M$238.91M$3.28B$270.77M7 Day Performance-0.18%2.63%0.98%3.36%1 Month Performance3.35%3.08%7.20%6.41%1 Year Performance-3.18%20.54%63.06%28.26% Progyny Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PGNYProgyny3.7448 of 5 stars$22.51-2.8%$25.30+12.4%+1.2%$1.99B$1.17B38.15310Positive NewsRDNTRadNet3.427 of 5 stars$71.760.0%$71.60-0.2%+18.3%$5.52B$1.83B-358.7811,021Positive NewsInsider TradeOPCHOption Care Health4.8747 of 5 stars$28.68-0.2%$35.75+24.7%-9.4%$4.65B$5.37B22.948,088Positive NewsSHCSotera Health2.1627 of 5 stars$16.37+1.0%$16.00-2.3%-0.4%$4.65B$1.12B204.653,000Insider TradeBTSGBrightSpring Health Services2.8159 of 5 stars$23.69-0.2%$25.67+8.3%+107.0%$4.20B$11.27B76.4235,000News CoverageAnalyst ForecastWGSGeneDx2.5773 of 5 stars$129.49+0.4%$101.63-21.5%+257.0%$3.72B$305.45M2,589.801,200Positive NewsAnalyst ForecastCONConcentra Group Holdings Parent3.0353 of 5 stars$23.78+0.2%$27.50+15.7%-3.7%$3.05B$1.90B19.9811,250Positive NewsSGRYSurgery Partners3.1614 of 5 stars$22.69-0.1%$33.00+45.4%-27.4%$2.91B$3.11B-15.8712,200Positive NewsPRVAPrivia Health Group4.5292 of 5 stars$23.04+5.6%$28.08+21.9%+25.5%$2.83B$1.74B209.47810Gap UpHTFLHeartflowN/A$31.50-2.0%N/AN/A$2.56BN/A0.00699Quiet Period ExpirationGap UpVCYTVeracyte3.8465 of 5 stars$30.34+1.3%$40.90+34.8%+5.1%$2.39B$445.76M91.94790Positive News Related Companies and Tools Related Companies RadNet Alternatives Option Care Health Alternatives Sotera Health Alternatives BrightSpring Health Services Alternatives GeneDx Alternatives Concentra Group Holdings Parent Alternatives Surgery Partners Alternatives Privia Health Group Alternatives Heartflow Alternatives Veracyte Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PGNY) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredCollege grad makes $64,000 a monthIt's easy to feel like you've missed out on the biggest stock market boom of the century. But if you want t...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Progyny, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Progyny With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PGNY Stock Alerts